---
title: "Gyre Therapeutics (GYRE.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/GYRE.US/norm.md"
symbol: "GYRE.US"
name: "Gyre Therapeutics"
parent: "https://longbridge.com/en/quote/GYRE.US.md"
datetime: "2026-05-21T03:24:48.967Z"
locales:
  - [en](https://longbridge.com/en/quote/GYRE.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/GYRE.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/GYRE.US/norm.md)
---

# Gyre Therapeutics (GYRE.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0961 | -0.0218 | 0.0349 | 0.0022 | 0.0043 |
| ROE | -33.53% | -6.63% | 14.89% | 2.21% | 16.42% |
| Revenue | 22.52M | 37.20M | 30.56M | 26.77M | 22.06M |
| Net income | -8.69M | -1.72M | 3.61M | 442000.00 | 2.70M |
| Operating income | -6.80M | 120000.00 | 6.93M | 2.17M | 2.27M |
| Gross margin | 94.55% | 95.31% | 94.67% | 95.70% | 95.95% |
| Net margin | -38.59% | -4.63% | 11.81% | 1.65% | 12.23% |
| Profit quality | -213.90% | -2.13% | 148.12% | 104.02% | -1762.02% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 162.01M | 166.13M | 159.38M | 152.65M | 129.79M |
| Leverage | 1.18 | 1.17 | 1.16 | 1.18 | 1.24 |
| BVPS | 1.11 | 1.16 | 1.12 | 1.01 | 0.7773 |
| Turnover | 0.8022 | 0.7998 | 0.7537 | 0.7471 | 0.7994 |
| Cash & STI | 49.81M | 52.42M | 60.05M | 54.37M | 29.89M |
| Inv & Rec | 11.35M | 10.17M | 8.85M | 8.86M | 7.88M |
| LT assets | 23.57M | 24.73M | 24.91M | 24.90M | 25.12M |
| Net debt | -48.98M | -51.49M | -58.88M | -52.97M | -28.31M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 3.18M | -5.63M | 4.68M | 2.09M | -129000.00 |
| Investing CF | -3.06M | 1.85M | -1.25M | -3.04M | 1.97M |
| Financing CF | 21000.00 | 318000.00 | 365000.00 | 22.35M | 1.34M |
| Free CF | 8.23M | -3.83M | 2.82M | 2.37M | 582625.00 |
| OCF coverage | 1786.52% | -3906.25% | 700.00% | 815.63% | -105.74% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -178000.00 | -144000.00 | -668000.00 | -256000.00 | -122000.00 |

## Distribution Plan

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.24USD | 2023-01-05 | 2023-01-13 | 2023-01-12 |
| Cash Dividend: 
1.43USD | 2022-09-06 | 2022-09-21 | 2022-09-20 |
| Cash Dividend: 
0.5692USD | 2015-08-14 | 2015-08-20 | 2015-08-19 |